Evidence map›Paper›PMID 26997483›Full record

ArticleCell2016

The Effect of Sustained Inflammation on Hepatic Mevalonate Pathway Results in Hyperglycemia.

Daniel Okin, Ruslan Medzhitov

Open access · bronzeAbstract read
In one paragraph

Article in Cell, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed, 1 pooled it
11.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 1 synthesis or guideline pooled it, 121 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. GNature communications · 2024
    Article
  10. Article
  11. Article
  12. Review
  13. Statins in Mitigating Anticancer Treatment-Related Cardiovascular Disease.International journal of molecular sciences · 2024
    Review
  14. Article
  15. Review
  16. NOD1: a metabolic modulator.Frontiers in endocrinology · 2024
    Review
  17. Review
  18. Article
  19. Article
  20. Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Daniel OkinDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA.
Ruslan MedzhitovDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA; Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, CT 06520, USA. Electronic address: ruslan.medzhitov@yale.edu.
Howard Hughes Medical Institute · USYale University · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007205 · NIGMS · YALE UNIVERSITY · PI KAZMIERCZAK, BARBARA I · 1985 to 2019
$42.9M
Yale Liver CenterP30DK034989 · NIDDK · YALE UNIVERSITY · PI WAJAHAT Zafar MEHAL · 1986 to 2026
$31.1M
Yale Mouse Metabolic Phenotyping CenterU24DK059635 · NIDDK · YALE UNIVERSITY · PI SHULMAN, GERALD I · 2001 to 2015
$8.9M
Cell Biology of TLR Signal TransductionR37AI046688 · NIAID · YALE UNIVERSITY · PI MEDZHITOV, RUSLAN · 2006 to 2015
$3.8M
Toll Pathway & Control of Adaptive Immune ResponsesR01AI055502 · NIAID · YALE UNIVERSITY · PI MEDZHITOV, RUSLAN · 2003 to 2013
$3.7M
Role of basophils in initiating Th2 immune responsesR01AI089771 · NIAID · YALE UNIVERSITY · PI MEDZHITOV, RUSLAN · 2010 to 2014
$2.0M
Memory of DNA DamageR01CA157461 · NCI · YALE UNIVERSITY · PI MEDZHITOV, RUSLAN · 2011 to 2015
$1.7M
TOLL RECEPTORS AND CONTROL OF MAMMALIAN IMMUNITYR01AI046688 · NIAID · YALE UNIVERSITY · PI MEDZHITOV, RUSLAN · 2001 to 2005
$1.5M
Yale Mouse Metabolic Phenotyping CenterU2CDK059635 · NIDDK · YALE UNIVERSITY · PI SHULMAN, GERALD I · 2016 to 2016
$493k
The role of inflammatory cytokines in the regulation of hepatic insulin signalingF30DK094480 · NIDDK · YALE UNIVERSITY · PI OKIN, DANIEL · 2012 to 2014
$122k
Howard Hughes Medical InstituteNCI NIH HHS CA157461NCI NIH HHS R01 CA157461NIAID NIH HHS AI046688NIAID NIH HHS AI089771NIAID NIH HHS R01 AI046688NIAID NIH HHS R01 AI055502NIAID NIH HHS R01 AI089771NIAID NIH HHS R37 AI046688NIDDK NIH HHS 1F30DK094480NIDDK NIH HHS DK059635NIDDK NIH HHS F30 DK094480NIDDK NIH HHS P30 DK034989NIDDK NIH HHS U24 DK059635NIGMS NIH HHS 2T32GM7205-36NIGMS NIH HHS T32 GM007205
6 · The paper itself

Abstract

Control of plasma glucose level is essential to organismal survival. Sustained inflammation has been implicated in control of glucose homeostasis in cases of infection, obesity, and type 2 diabetes; however, the precise role of inflammation in these complex disease states remains poorly understood. Here, we find that sustained inflammation results in elevated plasma glucose due to increased hepatic glucose production. We find that sustained inflammation suppresses CYP7A1, leading to accumulation of intermediate metabolites at the branch point of the mevalonate pathway. This results in prenylation of RHOC, which is concomitantly induced by inflammatory cytokines. Subsequent activation of RHO-associated protein kinase results in elevated plasma glucose. These findings uncover an unexpected mechanism by which sustained inflammation alters glucose homeostasis.

Indexed as

Biosynthetic PathwaysAnimalsBlood GlucoseChemical and Drug Induced Liver InjuryCholesterol 7-alpha-HydroxylaseFastingHepatitisHyperglycemiaLipopolysaccharidesMevalonic AcidMiceMice, ObeseProtein Prenylationras Proteinsrho-Associated KinasesrhoC GTP-Binding ProteinBlood GlucoseCholesterol 7-alpha-HydroxylaseCyp7a1 protein, mouseLipopolysaccharidesMevalonic Acidras Proteinsrho-Associated KinasesrhoC GTP-Binding ProteinRhoc protein, mouseTriglycerides

Identifiers

PMID26997483
PMCPMC4826308
OpenAlexW2297269161

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.